Skip to main content

TD Asset Management Inc

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1056053 Toronto, A6

Position in HALO

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$75,530,883
+$12,827,204 QoQ
Shares Held
1,168,666
+25.4% QoQ
Ownership
0.985%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
15 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

TD Asset Management Inc holds $1,314,505,240 across 121 Biotechnology names. HALO ranks #4 (5.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 HALO
Halozyme Therapeutics, Inc.
This page
1,168,666 $75,530,883

All Filings in HALO

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $75,530,883 1,168,666
2025-12-31 $62,703,679 931,704
2025-09-30 $75,919,367 1,035,170
2025-06-30 $56,741,335 1,090,760
2025-03-31 $92,642,038 1,451,842
2024-12-31 $65,601,726 1,372,134
2024-09-30 $88,764,128 1,550,736
2024-06-30 $123,882,869 2,365,983
2024-03-31 $103,378,700 2,541,266
2023-12-31 $73,325,535 1,983,916
2023-09-30 $12,282,293 321,526
2023-06-30 $11,597,442 321,526
2023-03-31 $12,279,077 321,526
2022-12-31 $10,406,156 182,885
2020-06-30 $530,838 19,800